Plain-English translation of NCT07458191 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This is an observational study that monitors patients taking , a blood-thinning medication, to treat nonvalvular atrial fibrillation (an irregular heart rhythm). Researchers want to understand how safe this medication is for patients and whether people take it as prescribed. The study will follow about 800 patients over six months to track any bleeding, side effects, and how well patients stick to their treatment plan.
is used to prevent blood clots in people with irregular heart rhythms, but doctors need to understand how well it works in real-world patients and whether any safety concerns arise. This study will help doctors learn how to best use this medication and support patients in taking it correctly.
You likely qualify if…
You likely don't qualify if…
You will be followed for six months with four scheduled visits to check on your health and how you are managing the medication. The first and last visits will be in person; the middle visits may be done by phone if that works for you. Researchers will ask about any bleeding, side effects, and whether you are taking the medication as prescribed. If you experience any serious bleeding or reactions, your doctor will arrange an unscheduled appointment to address it right away.
AI-generated summary from trial data · Jun 11, 2026 · Not medical advice
Bosnia and Herzegovina